
Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system
Author(s) -
Shiguang Zhu,
Li Ren,
Yuxiang Wang,
Wei Feng,
Juan Li,
Rong Qiu
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i25.3823
Subject(s) - proliferating cell nuclear antigen , esophagectomy , medicine , esophageal cancer , stage (stratigraphy) , carcinoma , cancer , immunohistochemistry , proportional hazards model , pathology , log rank test , oncology , survival analysis , radiation therapy , gastroenterology , biology , paleontology
The aim of the present study is to use immunohistochemical methods to investigate the clinical implications of tumor markers in esophageal squamous cell carcinoma and evaluate their impact on prognosis.